186 related articles for article (PubMed ID: 36580664)
1. Type 2B von Willebrand disease mutations differentially perturb autoinhibition of the A1 domain.
Legan ER; Liu Y; Arce NA; Parker ET; Lollar P; Zhang XF; Li R
Blood; 2023 Mar; 141(10):1221-1232. PubMed ID: 36580664
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets.
Casari C; Paul DS; Susen S; Lavenu-Bombled C; Harroche A; Piatt R; Poe KO; Lee RH; Bryckaert M; Christophe OD; Lenting PJ; Denis CV; Bergmeier W
Blood Adv; 2018 Jun; 2(12):1417-1428. PubMed ID: 29925524
[TBL] [Abstract][Full Text] [Related]
3. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R
J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141
[TBL] [Abstract][Full Text] [Related]
4. The co-influence of VWD type 2B/2M mutations in the A1 domain and platelet GPIbα on the rate of cleavage to VWF by ADAMTS13.
Ma Z; Su J; Zhang J; Ling J; Yin J; Bai X; Ruan C
Thromb Res; 2015 Nov; 136(5):987-95. PubMed ID: 26345337
[TBL] [Abstract][Full Text] [Related]
5. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
Yago T; Lou J; Wu T; Yang J; Miner JJ; Coburn L; López JA; Cruz MA; Dong JF; McIntire LV; McEver RP; Zhu C
J Clin Invest; 2008 Sep; 118(9):3195-207. PubMed ID: 18725999
[TBL] [Abstract][Full Text] [Related]
6. The impact of aberrant von Willebrand factor-GPIbα interaction on megakaryopoiesis and platelets in humanized type 2B von Willebrand disease model mouse.
Kanaji S; Morodomi Y; Weiler H; Zarpellon A; Montgomery RR; Ruggeri ZM; Kanaji T
Haematologica; 2022 Sep; 107(9):2133-2143. PubMed ID: 35142156
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα.
Ju L; Dong JF; Cruz MA; Zhu C
J Biol Chem; 2013 Nov; 288(45):32289-32301. PubMed ID: 24062306
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations.
Dumas JJ; Kumar R; McDonagh T; Sullivan F; Stahl ML; Somers WS; Mosyak L
J Biol Chem; 2004 May; 279(22):23327-34. PubMed ID: 15039442
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease.
Tischer A; Brehm MA; Machha VR; Moon-Tasson L; Benson LM; Nelton KJ; Leger RR; Obser T; Martinez-Vargas M; Whitten ST; Chen D; Pruthi RK; Bergen HR; Cruz MA; Schneppenheim R; Auton M
J Mol Biol; 2020 Jan; 432(2):305-323. PubMed ID: 31628947
[TBL] [Abstract][Full Text] [Related]
10. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR
Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222
[TBL] [Abstract][Full Text] [Related]
11. An update on type 2B von Willebrand disease.
Mikhail S; Aldin ES; Streiff M; Zeidan A
Expert Rev Hematol; 2014 Apr; 7(2):217-31. PubMed ID: 24521271
[TBL] [Abstract][Full Text] [Related]
12. A novel platelet-type von Willebrand disease mutation (GP1BA p.Met255Ile) associated with type 2B "Malmö/New York" von Willebrand disease.
Lavenu-Bombled C; Guitton C; Dupuis A; Baas MJ; Desconclois C; Dreyfus M; Li R; Caron C; Gachet C; Fressinaud E; Lanza F
Thromb Haemost; 2016 Nov; 116(6):1070-1078. PubMed ID: 27683759
[TBL] [Abstract][Full Text] [Related]
13. Changes in thermodynamic stability of von Willebrand factor differentially affect the force-dependent binding to platelet GPIbalpha.
Auton M; Sedlák E; Marek J; Wu T; Zhu C; Cruz MA
Biophys J; 2009 Jul; 97(2):618-27. PubMed ID: 19619477
[TBL] [Abstract][Full Text] [Related]
14. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
de Romeuf C; Hilbert L; Mazurier C
Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of regulation of von Willebrand factor binding to glycoprotein Ib.
Blenner MA; Dong X; Springer TA
J Biol Chem; 2014 Feb; 289(9):5565-79. PubMed ID: 24391089
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of type 2 von Willebrand disease.
Fressinaud E; Mazurier C; Meyer D
Int J Hematol; 2002 Jan; 75(1):9-18. PubMed ID: 11843298
[TBL] [Abstract][Full Text] [Related]
17. A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis.
Casonato A; Sartorello F; Pontara E; Gallinaro L; Bertomoro A; Grazia Cattini M; Daidone V; Szukowska M; Pagnan A
Thromb Haemost; 2007 Dec; 98(6):1182-7. PubMed ID: 18064311
[TBL] [Abstract][Full Text] [Related]
18. von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin αIIbβ3.
Casari C; Berrou E; Lebret M; Adam F; Kauskot A; Bobe R; Desconclois C; Fressinaud E; Christophe OD; Lenting PJ; Rosa JP; Denis CV; Bryckaert M
J Clin Invest; 2013 Dec; 123(12):5071-81. PubMed ID: 24270421
[TBL] [Abstract][Full Text] [Related]
19. GPIbα-vWF rolling under shear stress shows differences between type 2B and 2M von Willebrand disease.
Coburn LA; Damaraju VS; Dozic S; Eskin SG; Cruz MA; McIntire LV
Biophys J; 2011 Jan; 100(2):304-12. PubMed ID: 21244826
[TBL] [Abstract][Full Text] [Related]
20. Variability in platelet- and collagen-binding defects in type 2M von Willebrand disease.
Larsen DM; Haberichter SL; Gill JC; Shapiro AD; Flood VH
Haemophilia; 2013 Jul; 19(4):590-4. PubMed ID: 23496210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]